Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2K(d)54-68) that mediate transplant rejection

Transplantation

Volumn 70, Issue 10, 2000, Pages 1516-1524

  Honjo, Kazuhito ^a   Xu, Xiaoyan ^a   Bucy, R Pat ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; H2 ANTIGEN; H2K ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ALLOGRAFT;

EID: 0034722722     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200011270-00020     Document Type: Article

References (44)

1. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
2. Improved technique of heart transplantation in rats
3. Immunosuppression by inhibition of cellular adhesion mediated by LFA-1/ICAM-1 in murine cardiac transplantation
4. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
5. Inhibition of pulmonary eosinophilia in P-selectin- and ICAM-1-deficient mice
6. Structural diversity of the classical H-2 genes: K, D, and L
7. Role of indirect allorecognition in allograft rejection
8. The role of polymorphic donor peptides in allograft recognition and rejection
9. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?
10. Antigen processing and presentation in transplantation
11. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
12. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection
13. Mechanisms of allo-recognition: Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells
14. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation
15. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection
16. Role of indirect allorecognition in experimental late acute rejection
17. Contribution of direct and indirect recognition pathways to T cell alloreactivity
18. Alloantigenicity of human endothelial cells: III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytes
19. + T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs
20. Indirect recognition of donor HLA-DR peptides in organ allograft rejection
21. Indirect recognition of donor MHC Class II antigens in human transplantation
22. Mechanism of liver allograft rejection: The indirect recognition pathway
23. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
24. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
25. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans
26. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome
27. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat
28. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression
29. Mechanisms of indirect allorecognition in graft rejection: Class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo
30. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides
31. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts
32. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides
33. Characterization and manipulation oft cell immunity to skin grafts expressing a transgenic minor antigen
34. Identification of an indirectly presented epitope in a mouse model of skin allograft rejection
35. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice
36. Cytokine gene transcription in vascularised organ grafts: Analysis using semiquantitative polymerase chain reaction
37. + T cells in vivo: Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts
38. Heart allografts in routine systems. The differential activation of Th2-like effector cells in peripheral tolerance
39. Tumor necrosis factor alpha in human kidney transplant rejection: Analysis by in situ hybridization
40. Detection of IL-1β and TNF-α message and protein in renal allograft biopies
41. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult
42. Recombinant human interleukin 5 is a selective activator of human eosinophil function
43. Release of granule proteins from eosinophils cultured with IL-5
44. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice